PATENT CLAIM ANALYSIS

Application Number: 16282880
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-10
Patent Classification: ["514", "560000"]

Abstract:
The present invention relates generally to methods for the treatment and/or prophylaxis of neurological diseases and disorders involving administration of trans 10-HDA. In particular, the methods of the present invention are useful in the treatment and/or prophylaxis of acquired or progressive neurodevelopmental disorders and conditions in mammals. More particularly, methods are taught herein for the treatment and/or prophylaxis of diseases and disorders such as autism spectrum disorders.

Claim (Index 23):
A therapeutic agent for use according to  claim 22  wherein the disease or disorder is selected from the group consisting of Autistic Disorder, Asperger's Disorder, Childhood Disintegrative Disorder and Pervasive Developmental Disorder-Not Otherwise Specified, and Rett syndrome.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15892144', '15316110', '15103470', '14925007', '15004218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8214888615205453
- 35 USC 102 Novelty (BERT): 0.5869289432278297
- Combined Prediction Score: 0.7980328696912738
- Mean Citation Score: 336.2826980000001
- Max Citation Score: 544.0127
- Similarity Product: 401.742418550086

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test